21/10/2022 08:00 AM - 21/10/2022 04:00 PM
Aspetar and Cedars-Sinai Symposium on Orthobiologics
It is with great pleasure that we invite you to attend the Aspetar and Cedars-Sinai Symposium on the 21st of October 2022. Aspetar, in partnership with Cedar-Sinai, will deliver sessions that examine the use of Orthobiologics within Orthopaedic Surgery, Sports Medicine, and Rehabilitation. An international panel of practitioners will discuss the properties, use, evidence and influence of Orthobiologics.
DHP accreditation statement:
This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health’s Department of Healthcare Professions - Accreditation Section and is approved for a maximum of 3.0 hours. This CPD activity was developed in partnership with Cedars-Sinai.
Activity Code: HGI-03-P111
Target Audience:
Physicians, Allied Healthcare Practitioners (Physiotherapists only), Others (including but not restricted to Researchers, Coaches and Managers)
Date:
Friday 21st October 2022
Time:
13:00-17:10
Venue:
Aspetar Auditorium and online
Overall Learning Objectives:
By the end of this event, participants will be able to:
- Outline different orthobiologics and their properties
- Discuss current evidence on Platelet-Rich Plasma (PRP) and stem cell therapies
- Understand how the use of orthobiologics influences surgery and rehabilitation
Faculty Disclosure:
It is the policy of Aspetar Orthopedic and Sports Medicine Hospital to adhere to DHP accreditation standards, and Aspetar CME CPD policies to ensure fair balance, independence, objectivity, and scientific rigor in all its CPD activities. The Scientific Planning Committee, speakers, moderators, facilitators, and/or authors participating in CPD activities are expected to disclose relevant financial relationships pertaining to their contribution to the activity. Relationship information is analyzed to determine whether conflicts of interest exist. All conflicts of interest are resolved prior to participation in the planning or implementation of this activity. Presenters and authors are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
Aspetar CPD activities are intended to be evidence-based, balanced, and free of commercial bias. If you have any concerns, please contact CME/CPD Unit
at 2363-4413 to anonymously express them.
Scientific Planning Committee:
Markus Laupheimer (Co-Chair), Bert Mandelbaum (Co-Chair), Clive Svendsen, Dmitriy Sheyn, Sofie Nelis, Reem AlKuthairi, Emmanouil Papakostas, Elisabet Hagert, Theodorakys Marin and Martina Emersic
CPD Coordinator: Leonora B. Jarder
The Scientific Planning Committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators, and/or authors in advance of the CPD activity and has implemented procedures to manage any potential or real conflicts of interest.
CME/CPD Unit Staff: Have nothing to disclose.
EVALUATION: An anonymous evaluation will be provided to participants at the end of the activity. The evaluation allows us to assess the degree to which the activity met its objectives. It will also guide the planning of future activities and improving the educational program based on informed decisions.